Program at a Glance

Venue Breakout Session(301)
Registration 11:00-16:00
13:20-15:00
(100 mins)

Postgraduate Course 1
×

Postgraduate Course 1

June 23, 2022（Thursday）13:20-15:00 (GMT+8)
Moderator：Ming-Chih Ho (Taiwan)
Moderator：Yoh Zen (Japan)
Conference Room：301

Time Topic Speaker
13:20-13:40 Prevention of HCC (Primary, Secondary, Tertiary) Tung-Hung Su (Taiwan)
13:40-14:00 Pathology Diagnosis of HCC Yoh Zen (Japan)
14:00-14:20 Art of The State of CT and MRI for HCC Bang-Bin Chen (Taiwan)
14:20-14:40 Surgery For Liver Cancer Ming-Chih Ho (Taiwan)
14:40-15:00 Radiofrequency and Microwave Ablation of Liver Cancers Kai-Wen Huang (Taiwan)
15:00-15:20
(20 mins)		 Coffee Break
15:20-17:00
(100 mins)

Postgraduate Course 2
×

Postgraduate Course 2

June 23, 2022（Thursday）15:20-17:00 (GMT+8)
Moderator：Po-Chin Liang (Taiwan)
Moderator：Han Chong Toh (Singapore)
Conference Room：301

Time Topic Speaker
15:20-15:40 Liver Transplantation for HCC: Criteria & Outcomes Cheng-Maw Ho (Taiwan)
15:40-16:00 TACE and TARE for HCC Yi-Sheng Liu(Taiwan)
16:00-16:20 Radiotherapy for HCC Bing-Shen Huang (Taiwan)
16:20-16:40 Systemic Therapy of HCC Han Chong Toh (Singapore)
16:40-17:00 Systemic Therapy of Cholangiocarcinoma Nai-Jung Chiang (Taiwan)
18:30-21:00
(150 mins)		 Faculty Night
by Invitation only
Venue Breakout Session(301) Breakout Session(401) Breakout Session(402) Plenary Session(201)
Registration 07:00-16:00
Poster & Exhibition 09:00-17:00
08:00-09:40
(100 mins)

HBV-HCC: basic and clinical 1
×

HBV-HCC: basic and clinical 1

June 24, 2022（Friday）08:00-09:40 (GMT+8)
Moderator：Jia-Horng Kao (Taiwan)
Moderator：Young-Suk Lim (South Korea)
Conference Room：301

Time Topic Speaker
08:00-08:25 Natural History and Carcinogenesis of HBV Infection Rong-Nan Chien (Taiwan)
08:25-08:50 Biomarkers Predictive of HBV-HCC Tai-Chung Tseng (Taiwan)
08:50-09:15 Risk Prediction Models of HBV-HCC Hwai-I Yang(Taiwan)
09:15-09:40 Prevention of Hepatitis B Virus-Related Hepatocellular Carcinoma Young-Suk Lim (South Korea)

HCV-HCC: basic and clinical 2
×

HCV-HCC: basic and clinical 2

June 24, 2022（Friday）08:00-09:40 (GMT+8)
Moderator：Ming-Lung Yu (Taiwan)
Moderator：Yasuhito Tanaka (Japan)
Conference Room：401

Time Topic Speaker
08:00-08:25 Risk Stratification of HCV-HCC before and after HCV Cure Chen-Hua Liu (Taiwan)
08:25-08:50 Genetic Factors Associated with HCC Development after HCV Eradication Yasuhito Tanaka (Japan)
08:50-09:15 Molecular Mechanisms Driving HCC of HCV-HCC after HCV cure Thomas F. Baumert (Germany)
09:15-09:40 Prognosis of HCV-related HCC Ming-Lung Yu (Taiwan)
09:40-10:00
(20 mins)		 Coffee Break
10:00-11:40
(100 mins)

MAFLD/NASH-HCC: basic and clinical 3-1
×

MAFLD/NASH-HCC: basic and clinical 3-1

June 24, 2022（Friday）10:00-11:40 (GMT+8)
Moderator：Han-Chieh Lin (Taiwan)
Moderator：Bin Gao (USA)
Conference Room：301

Time Topic Speaker
10:00-10:25 Pathogenesis of NASH and Liver Fibrosis Kuei-Chuan Lee (Taiwan)
10:25-10:50 Inflammation in Fatty Liver Disease Progression and Liver Cancer Bin Gao (USA)
10:50-11:15 MAFLD and NAFLD Diagnostic Criteria and Prevalence of Fibrosis in Asia and Western Patients. Jacob George (Australia)
11:15-11:40 Biomarkers for NAFLD/NASH and Its Treatment Response Vincent Wong (Hong Kong)

HCC Basic science, Genomic and molecular pathogenesis 4-1
×

HCC basic science, genomic and molecular pathogenesis 4-1

June 24, 2022（Friday）10:00-11:40 (GMT+8)
Moderator：Shiou Hwei Yeh (Taiwan)
Moderator：Hidewaki Nakagawa (Japan)
Conference Room：401

Time Topic Speaker
10:00-10:25 Cell-matrix Interaction in The Invasion and Metastasis of Liver Cancer Sen-Yung Hsieh (Taiwan)
10:25-10:50 Proteo-genomic Characterization of Virus-associated Liver Cancers Identifies Novel Subtypes and Therapeutic Strategies Hidewaki Nakagawa (Japan)
10:50-11:15 Novel Precision Mouse Models of Hepatocellular Carcinoma Amaia Lujambio (Spain)
11:15-11:40 Immunogenomic Classification of Primary Liver Cancer Daniela Sia (Italy)
Oral Presentation
11:40-13:00
(80 mins)		 Luncheon Symposium（Virtual）
(Medtronic)
13:00-14:40
(100 mins)

MAFLD/NASH-HCC: basic and clinical 3-2
×

MAFLD/NASH-HCC: basic and clinical 3-2

June 24, 2022（Friday）13:00-14:40 (GMT+8)
Moderator：Chia-Yen Dai (Taiwan
Moderator：Daniel Q. Huang (Singapore)
Conference Room：301

Time Topic Speaker
13:00-13:30 Global Epidemiology of NAFLD-related HCC: Trends, Risk Factors, and Surveillance Daniel Q. Huang (Singapore)
13:30-14:00 Risks and Clinical Predictors of Cirrhosis and Hepatocellular Carcinoma Diagnoses in Adults with Diagnosed NAFLD: Real-world Study of 18 Million Patients in Four European Cohorts William Alazawi (UK)
14:00-14:30 Diabetes and The Risk of Hepatocellular Carcinoma in Cirrhosis Patients with NAFLD Ju Dong Yang (South Korea)
14:30-14:40 Session Closing

HCC basic science, immunopathogenesis and microenvironment 4-2
×

HCC Basic science, Genomic and molecular pathogenesis 4-2

June 24, 2022（Friday）13:00-14:40 (GMT+8)
Moderator：Chun-Yen Lin (Taiwan)
Moderator：JunHao Hu (China)
Conference Room：401

Time Topic Speaker
13:00-13:25 Immune Regulation in Tumor Immunotherapy: The Role of PMN-MDSCs Chun-Yen Lin (Taiwan)
13:25-13:50 Hepatic Stellate Cell Activation Roadmap in Liver Fibrosis and Its Application JunHao Hu (China)
13:50-14:15 The Role of CD4+ T Cell in the HCC treatment Tim F. Greten (Germany)
14:15-14:40 The Role of Innate/Adaptive Immune Cells in NASH - Consequences for Liver Cancer Therapy Mathias Heikenwalder (Germany)
Oral Presentation
14:40-15:00
(20 mins)		 Coffee Break
15:00-15:20
(20 mins)		 Opening Ceremony
15:20-15:50
(30 mins)		 State-of-Art Lecture
National Policy and Achievement of HCC Control in Taiwan
Moderator：Han-Chieh Lin (Taiwan)
Speaker：Chien-Jen Chen (Taiwan)
Conference Room：201
15:50-16:20
(30 mins)		 Chairman Lecture
Towards Elimination of HBV and Related HCC: What We Learn From Professor Ding-Shinn Chen?
Moderator：Pei-Jer Chen (Taiwan)
Speaker：Chun-Jen Liu (Taiwan)
Conference Room：201
16:20-16:50
(30 mins)		 Keynote Lecture(1)
Recent Progress and Future Directions of HCC Systemic Therapies: The Need for HCC-specific Targets and Regimens
Moderator：Chien-Jen Chen (Taiwan)
Speaker：Pei-Jer Chen (Taiwan)
Conference Room：201
16:50-18:10
(80 mins)		 Evening Symposium
(BMS/Ono)		 Evening Symposium
(MSD)		 Evening Symposium
(Gilead & Harvester)
18:30-21:30
(180 mins)		 Gala Dinner
Venue Breakout Session(301) Breakout Session(401) Breakout Session(402) Plenary Session(201)
Registration 07:00-14:30
Poster & Exhibition 09:00-15:30
08:00-09:30
(90 mins)

HCC diagnosis 5
×

HCC diagnosis 5

June 25, 2022（Saturday）08:00-09:30 (GMT+8)
Moderator：Shiu-Feng Huang (Taiwan)
Moderator：Young Nyun Park (South Korea)
Conference Room：301

Time Topic Speaker
08:00-08:20 Pathology Diagnosis of Hepatocellular Carcinoma Young Nyun Park (South Korea)
08:20-08:40 Immune Checkpoint Inhibitor-Related Liver Injury in HCC and Non-HCC Patients Yoh Zen (Janpn)
08:40-09:00 Contrast-enhanced Ultrasound of Liver Tumor: Pros and Cons Yi-Hong Chou (Taiwan)
09:00-09:20 State-of-the-art MRI for HCC Yu Ting Kuo (Taiwan)
09:20-09:30 Session Closing

Epidemiology and prevention of HCC 11
×

Epidemiology and prevention of HCC 11

June 25, 2022（Saturday）08:00-09:30 (GMT+8)
Moderator：Sheng-Nan Lu (Taiwan)
Moderator：Yasuhiro Asahina (Japan)
Conference Room：401

Time Topic Speaker
08:00-08:20 Global Trends, Determinants, and Prevention of Hepatocellular Carcinoma Hye-Won Lee (South Korea)
08:20-08:40 Genetic Predisposition to Hepatocellular Carcinoma Mei-Hsuan Lee (Taiwan)
08:40-09:00 Biomarkers for The Screening and Early Detection of Hepatocellular Carcinoma Yasuhiro Asahina (Japan)
09:00-09:20 The National HCC Multidisciplinary Team Improves Clinical Care Quality Sheng-Nan Lu (Taiwan)
09:20-09:30 Session Closing
Oral Presentation
09:30-09:55
(25 mins)		 Keynote Lecture(2)
Current Issues in HCC Surveillance
Moderator：Yi-Hsiang Huang (Taiwan)
Speaker：Amit G. Singal (U.S.A.)
Conference Room：201
09:55-10:20
(25 mins)		 Keynote Lecture(3)
Gut Microbiota and HCC
Moderator：Jia-Horng Kao (Taiwan)
Speaker：Ming-Shiang Wu (Taiwan)
Conference Room：201
10:20-10:35
(15 mins)		 Coffee Break
10:35-11:00
(25 mins)		 Keynote Lecture(4)
Unmet Needs in HCC Therapy
Moderator：Chun-Jen Liu (Taiwan)
Speaker：Richard S. Finn (U.S.A.)
Conference Room：201
11:00-12:30
(90 mins)

HCC treatment – curative treatment 6
×

HCC treatment – curative treatment 6

June 25, 2022（Saturday）11:00-12:30 (GMT+8)
Moderator：Shi-Ming Lin (Taiwan)
Moderator：Shuichiro Shiina (Japan)
Conference Room：301

Time Topic Speaker
11:00-11:20 Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma Jai Young Cho (South Korea)
11:20-11:40 Prognostic Impact of Concurrent Nonalcoholic Fatty Liver Disease in Patients with Chronic Hepatitis B‐related Hepatocellular Carcinoma Yoon Jun Kim (South Korea)
11:40-12:00 Microwave and Radiofrequency Ablation for Hepatocellular Carcinoma Shuichiro Shiina (Japan)
12:00-12:20 Non-Thermal Ablation for Hepatocellular Carcinoma over Risky Area. Kai-Wen Huang (Taiwan)
12:20-12:30 Session Closing

HCC treatment – systemic therapy 8
×

HCC treatment – systemic therapy 8

June 25, 2022（Saturday）11:00-12:30 (GMT+8)
Moderator：Chiun Hsu (Taiwan)
Moderator：Masatoshi Kudo (Japan)
Conference Room：401

Time Topic Speaker
11:00-11:20 Incorporating New Regimens of Systemic Therapy into Current Practice in Asia Stephen L. Chan (Hong Kong)
11:20-11:40 Changing Practice of Systemic Treatment for Intermediate-stage HCC in Japan Masatoshi Kudo (Japan)
11:40-12:00 Role of Molecular Targeted Agents in the Era of ICI-based Combination Therapy in Advanced HCC Yi-Hsiang Huang (Taiwan)
12:00-12:20 Perspective of Systemic Therapy for Hepatocellular Carcinoma. Ann-Lii Cheng (Taiwan)
12:20-12:30 Session Closing
12:30-13:50
(80 mins)		 Luncheon Symposium
(Roche)		 Luncheon Symposium
(Bayer)		 Luncheon Symposium
(Eisai)		 Luncheon Symposium
(Gilead & Harvester)
13:50-15:20
(90 mins)

HCC treatment – interventional radiology 7
×

HCC treatment – interventional radiology 7

June 25, 2022（Saturday）13:50-15:20 (GMT+8)
Moderator：Rheun-Chuan Lee (Taiwan)
Moderator：Toshihiro Tanaka (Japan)
Conference Room：301

Time Topic Speaker
13:50-14:10 釔90、cTACE Riad Salem (USA)
14:10-14:30 Superselective Conventional TACE for Hepatocellular Carcinoma Shiro Miyayama (Japan)
14:30-14:50 Role of DEB-TACE in The New Era of Systemic Therapy Toshihiro Tanaka (Japan)
14:50-15:10 Lipiodol-CT Guided Liver Tumor Ablation Po-Chin Liang (Taiwan)
15:10-15:30 Session Closing

Cholangiocarcinoma 9
×

Cholangiocarcinoma 9

June 25, 2022（Saturday）13:50-15:20 (GMT+8)
Moderator：Li-Tzong Chen (Taiwan)
Moderator：Do-Youn Oh (South Korea)
Conference Room：401

Time Topic Speaker
13:50-14:10 Pathology Diagnosis of Cholangiocarcinoma Young Nyun Park (South Korea)
14:10-14:30 Immunotherapy in Biliary Tract Cancer Do-Youn Oh (South Korea)
14:30-14:50 Precision Medicine in Biliary Tract Cancer Ming-Huang Chen (Taiwan)
14:50-15:10 Chemotherapy in BTC Li-Tzong Chen (Taiwan)
15:10-15:30 Session Closing
15:20-15:40
(20 mins)		 Coffee Break
15:40-17:10
(90 mins)

AI for HCC 10
×

AI for HCC 10

June 25, 2022（Saturday）15:40-17:10 (GMT+8)
Moderator：Tung-Hung Su (Taiwan)
Moderator：Julien Calderaro (France)
Conference Room：301

Time Topic Speaker
15:40-16:00 State-of-the-art of AI in Radiology for the Diagnosis of HCC Michael D. Kuo (Hong Kong)
16:00-16:20 AI in The Diagnosis and Management of HCC by Electric Medical Record Masaya Sato (Japan)
16:20-16:40 Application of AI in Pathology for The Diagnosis of HCC Julien Calderaro (France)
16:40-17:00 AI in the Diagnosis and Management of HCC by Multi-Omics Integration Bin Chen (USA)
17:00-17:10 Session Closing

AP region HCC summit 12
×

AP region HCC summit 12

June 25, 2022（Saturday）15:40-17:10 (GMT+8)
Moderator：Jia-Horng Kao(Taiwan)、Ann-Lii Cheng(Taiwan)
Moderator：Shiv Kumar Sarin (India)
Conference Room：401

Time Topic Speaker
15:40-15:55 Screening and Management of Hepatocellular Carcinoma in Vietnam Pham Cam Phuong (Vietnam)
15:55-16:10 Management of Hepatocellular Carcinoma in Philippines Diana Alcantara-Payawal (Philippines)
16:10-16:25 The Changing HCC Epidemiology and its Management Rosmawati Mohamed (Malaysia)
16:25-16:40 Management of Hepatocellular Carcinoma in Thailand Tawesak Tanwandee (Thailand)
16:40-16:55 Management of Hepatocellular Carcinoma in India Shiv Kumar Sarin (India)
16:55-17:10 Management of Hepatocellular Carcinoma in Indonesia Rino Gani (Indonesia)
17:20-17:40
(20 mins)		 Closing Ceremony